More News

01 May 2007 Cardiome Announces In-Licensing Agreement with Eli Lilly and Company
01 May 2007 Apollo develops needle-free topical vaccine
28 Apr 2007 Optaflu(R), the Novartis cell culture-derived influenza vaccine, receives positive opinion supporting European Union regulatory approval
28 Apr 2007 Kyowa Hakko in-licenses ARQ 197, an anticancer agent in clinical development, from the US company ArQule.
27 Apr 2007 Boston Scientific Announces Completion of Enrollment in Landmark Clinical Trial Comparing Drug-Eluting Stents To Cardiac Surgery
27 Apr 2007 Bristol-Myers Squibb and Pfizer Announce Worldwide Collaboration to Develop and Commercialize Anticoagulant and Metabolic Compounds
27 Apr 2007 Bristol-Myers Squibb and Pfizer Announce Worldwide Collaboration to Develop and Commercialize Anticoagulant and Metabolic Compounds
27 Apr 2007 SciClone Acquires Clinical-Stage Pancreatic Cancer Compound
27 Apr 2007 Ranbaxy Receives Final Us FDA Approval to Manufacture and Market Zolpidem Tablets in Usa
27 Apr 2007 Royalty Pharma and InNexus Biotechnology Announce Agreement Regarding the Purchase of Royalty Rights Based on DXL(TM) Antibody Products
27 Apr 2007 Alchemia reports preliminary positive efficacy data from HyCAMP Phase II trial
26 Apr 2007 MediGene Completes Patient Recruitment for Clinical Phase II Trial of EndoTAG(R)-1
26 Apr 2007 Alkermes and Indevus Announce Initiation of Phase 2a Clinical Study of ALKS 27 for the Treatment of COPD
26 Apr 2007 Ranbaxy Receives Us Fda Approval To Manufacture And Market Pravastatin Sodium Tablets In Usa
26 Apr 2007 ADVENTRX Announces Positive Data From Preclinical Pharmacokinetic Testing of ANX-514 (Docetaxel Emulsion)
26 Apr 2007 BDSI Announces Positive Phase III Clinical Trial Results for BEMA(TM) Fentanyl
26 Apr 2007 Dr. Reddy's Announces the Launch of Zolpidem Tartrate Tablets
26 Apr 2007 OctoPlus obtains full rights to PolyActive drug delivery technology from IsoTis
25 Apr 2007 Beyond biogenerics: the real threats for therapeutic proteins
25 Apr 2007 Neuromed Licenses Phase 3 Chronic Pain Product from ALZA Corporation
25 Apr 2007 Neuromed Licenses Phase 3 Chronic Pain Product from ALZA Corporation
25 Apr 2007 Wockhardt receives US FDA approval for anti-hypertensive drug
25 Apr 2007 Sciele Pharma to Acquire Alliant Pharmaceuticals, a Pediatric Specialty Pharmaceutical Company
24 Apr 2007 AstraZeneca to acquire MedImmune for $58 per share in a fully recommended, all-cash transaction with a total enterprise value of $15.2 billion
24 Apr 2007 Alimera Sciences' Medidur(TM) Trial Exceeds 500 Patient Mark In Phase 3 Trial Enrollment

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2021 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top